Sales/Maturities of Investments

$738.02M

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$738.02Mperiod endingJun 30, 2026

LGND Sales/Maturities of Investments ($27.50M → $738.02M)

Annual Sales/Maturities of Investments

High-resolution chart · PNG

LGND sales/maturities of investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Sales/Maturities of Investments — Annual fiscal periods (USD)
Period ending	Sales/Maturities of Investments (USD)
Dec 31, 2025	377,284,000
Dec 31, 2024	269,621,000
Dec 31, 2023	194,167,000
Dec 31, 2022	234,391,000
Dec 31, 2021	221,335,000
Dec 31, 2020	1,038,694,000
Dec 31, 2019	2,030,728,000
Dec 31, 2018	1,024,815,000
Dec 31, 2017	196,634,000
Dec 31, 2016	143,470,000
Dec 31, 2015	73,273,000
Dec 31, 2014	2,342,000
Dec 31, 2013	0
Dec 31, 2012	10,000,000
Dec 31, 2011	19,346,000
Dec 31, 2010	54,040,000
Dec 31, 2009	47,761,000
Dec 31, 2008	32,015,000
Dec 31, 2007	20,116,000
Dec 31, 2006	25,554,000
Dec 31, 2005	31,323,000
Dec 31, 2004	49,668,000
Dec 31, 2003	10,053,000
Dec 31, 2002	18,054,000
Dec 31, 2001	15,784,000
Dec 31, 2000	16,027,000
Dec 31, 1999	41,200,000
Dec 31, 1998	35,200,000
Dec 31, 1997	60,300,000
Dec 31, 1996	61,200,000
Dec 31, 1995	37,200,000
Dec 31, 1994	27,500,000